See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411879_2019_Innovus_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001411879, Innovus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,016,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,843,000 |
| 2 | PropertyPlantAndEquipmentNet | 247,000 |
| 3 | remainder_Assets | 21,000 |
| 4 | LiabilitiesCurrent | 7,353,000 |
| 5 | LiabilitiesNoncurrent | 2,665,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,325,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,991,000 |
| 9 | ResearchAndDevelopmentExpense | 160,000 |
| 10 | remainder_Expenses | 17,206,000 |
| 11 | remainder_Revenues | 23,990,000 |
| 12 | remainder_NetIncome | -2,587,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 10,127,000 |
| 1 | Liabilities | 10,018,000 |
| 2 | Expenses | 29,682,000 |
| 3 | Revenues | 23,990,000 |
| 4 | StockholdersEquity | 109,000 |
| 5 | NetIncome | -8,279,000 |
| 6 | ComprehensiveNetIncome | -8,279,000 |
| 7 | BaseVar | 38,202,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.798 |
| 9 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
